Last reviewed · How we verify
NCT05474703
Evaluation of the Effects of Levonorgestrel-releasing Intrauterine Device and Dydrogestreone on Quality of Life and Sexual Life in Patients With Abnormal Uterine Bleeding.
trial testing SF-36 Scores in Abnormal Uterine Bleeding in 171 participants. Status unknown.
24 July 2022
Quick facts
| Lead sponsor | Kanuni Sultan Suleyman Training and Research Hospital |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 171 |
| Start date | 20 February 2022 |
| Primary completion | 24 July 2022 |
| Estimated completion | 10 August 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- SF-36 Scores
Conditions studied
- Abnormal Uterine Bleeding — all drugs for Abnormal Uterine Bleeding →
Sponsor
Kanuni Sultan Suleyman Training and Research Hospital
Who can join
Adults 18 to 45, female only, with Abnormal Uterine Bleeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study was retrospectively collected from patients who were diagnosed with abnormal uterine bleeding and received oral dydrogesterone therapy for at least six months or who were administered an intrauterine device containing levonorgestrel at least six months ago, and prospectively Short form 36 (P-36); It covers the comparison of the Quality of Life Scale and the Female Sexual Function Scale (FSFI) by asking over the phone.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05474703
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Abnormal Uterine Bleeding
Currently open trials in the same condition.
- NCT07349108 — Comparison of Manual Vacuum Aspiration and Dilatation and Curettage for Endometrial Sampling Adequacy in Women With Abno · NA · active not recruiting
- NCT06653400 — Combined Ketorolac and Lidocaine Paracervical Block for Office Hysteroscopy · Phase 1 · recruiting
- NCT07496905 — The Effect of the Valsalva Maneuver in Endometrial Biopsy: A Randomized Controlled Trial · NA · recruiting
- NCT07169214 — Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding · Phase 1 · recruiting
- NCT07183501 — Combined Hystroscopic and Laparoscopic Repair of CS Scar Disorder · NA · recruiting
Other Kanuni Sultan Suleyman Training and Research Hospital trials
Trials by the same sponsor.
- NCT07519551 — Serum Myostatin and Irisin Levels in Postmenopausal Women: Association With Bone Mineral Density and Muscle Strength · not yet recruiting
- NCT07480330 — Serum Neurofilament Light Chain Levels and Neuropathy Severity in Diabetic Polyneuropathy · not yet recruiting
- NCT07425405 — Daily Screen Exposure and Preoperative Anxiety in Children Aged 2-5 Years · recruiting
- NCT07358754 — The Relationship Between Serum S100B and Brain-Derived Neurotrophic Factor · recruiting
- NCT07261436 — Performance Comparison of Large Language Models in TAP Block Ultrasound Interpretation · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05474703 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kanuni Sultan Suleyman Training and Research Hospital
- Last refreshed: 29 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05474703.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing